As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health ...

Citing topline data from its Phase 3 TRIUMPH-4, the Indiana-based drugmaker said that retatrutide, a GIP, GLP-1, and glucagon triple hormone receptor agonist, at the two highest doses led to ...

That’s why you should consider the best shampoos for curly hair. “While all hair needs cleansing, curly hair has its own set ...

As South Carolina public health officials work to stop the spread of measles following the current outbreak in the state, CVS ...

A new report highlights the company's role as a top U.S. employer, investing in improving health and supporting local communities.

CVS Health raises its 2025 revenue outlook as Bank of America highlights stronger margins, new tech investments, and momentum ...

CVS Health’s (NYSE: CVS) latest results affirm several points: their sales and adjusted profits remain stable, and they are adjusting their forecasts upward. Nonetheless, the quality of their profits ...

CVS Health’s 22.1% return over the past six months has outpaced the S&P 500 by 8.7%, and its stock price has climbed to $78.44 per share. This was partly thanks to its solid quarterly results, and the ...